Product news from the 09/12/06 News Brief

Share this article:
Barr Pharmaceuticals launched a generic version of its extended-cycle oral contraceptive Seasonale under the tradename Jolessa. The company launched this generic version of Seasonale following the final FDA approval of Watson Laboratories’ Abbreviated New Drug Application (ANDA) for a generic version of Seasonale. Watson received approval following the expiration of the Barr’s three-year new product exclusivity on Sept. 5, 2006. King Pharmaceuticals entered into an agreement with Ligand Pharmaceuticals to acquire rights to Avinza (morphine sulfate extended release). Avinza is an extended-release formulation of morphine and is indicated as a once-daily treatment for moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an extended period of time.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.

Sanofi wants greater MS role

The plan is to bring in-house products to the market as well as through acquisitions.

Mylan buys branded and generic Arixtra

The $225-million deal will give Mylan one of two generics for the deep vein thrombosis drug.